Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 215-951-9 | CAS number: 1459-93-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1990-1993
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods with acceptable restrictions
Data source
Reference
- Reference Type:
- publication
- Title:
- Evaluation of a three-exposure bone marrow micronucleus protocol: Results with 49 chemicals
- Author:
- Shelby MD, Erexson GL, Hook GL and Tice RR
- Year:
- 1 993
- Bibliographic source:
- Envir Molec Mutagen 21(2): 160-179
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- other: U.S. National Toxicology Program (NTP) Protocol for Bone Marrow Erythrocyte Micronucleus Assay
- Version / remarks:
- 1993
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- older version, 1993
- Deviations:
- yes
- Remarks:
- Bone marrow smears from each animal were evaluated for the percentage of PCE among 200 erythrocytes in this 1993 study, rather than the current requirement (2017) of 500 erythrocytes.
- Principles of method if other than guideline:
- Repeated exposure of animals to test substance, after which animals are euthanised and bone marrow from femurs is extracted and erythrocytes examined for evidence of micronucleated polychromatic cells. Cytotoxicity measures indicate whether test material was absorbed and bone marrow exposed.
- GLP compliance:
- no
- Remarks:
- but performed in the spirit of GLP according to U.S. NTP quality standards
- Type of assay:
- mammalian bone marrow chromosome aberration test
Test material
- Reference substance name:
- Dimethyl terephthalate
- EC Number:
- 204-411-8
- EC Name:
- Dimethyl terephthalate
- Cas Number:
- 120-61-6
- Molecular formula:
- C10H10O4
- IUPAC Name:
- dimethyl terephthalate
- Test material form:
- solid: crystalline
- Details on test material:
- dimethyl terephthalate. No information on purity
Constituent 1
- Specific details on test material used for the study:
- Identical substance as used in NTP assays, obtained from NTP Chemical Repository.
Vendor was Radian Corporation, Austin, TX, USA
Chemicals (n = 49) were coded and sent to two laboratories for testing. Data was analyzed and results were called before the test chemicals were decoded, to avoid bias.
Test animals
- Species:
- mouse
- Strain:
- B6C3F1
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- Mice were obtained from the NTP production facility at Taconic Farms.
Age was between 9 and 14 weeks.
Weight was 25-33 g, +/- 2 g.
Conditions used were those standard for in vivo NTP assays.
Idenification numbers were randomly assigned to mice prior to euthanasia.
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- Corn oil
- Details on exposure:
- The substance was prepated in corn oil and suspended using a Tek-Mar Tissumizer.
All test chemicals were administered within 30 minutes of preparation.
All IP treatments were at a volume of 0.4 ml per mouse.
Suspended DMBA (positive control) was stored at room temperature. - Duration of treatment / exposure:
- IP injection daily on 3 consecutive days
- Frequency of treatment:
- IP injection daily on 3 consecutive days
- Post exposure period:
- Generally, animals were observed/monitored twice daily.
Mice were euthanized with CO2 24 hours after the the third treatment.
Animals were euthanised with CO2 asphyxiation. Bone marrow was extracted for analysis of erythrocyte chromosomal material (2 slides/tissue/mouse).
Doses / concentrationsopen allclose all
- Dose / conc.:
- 1 750 mg/kg bw/day (actual dose received)
- Remarks:
- While the aim of the high dose was 2000 mg/kg (the limit dose), the dose of 1750 mg/kg was selected because the chemical could not be suspended in corn oil at concentrations that would permit higher doses.
- Dose / conc.:
- 875 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 438 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 0 mg/kg bw/day (actual dose received)
- No. of animals per sex per dose:
- 5-7
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- yes: 9,10-dimethylbenzanthracene;
- Justification for choice of positive control(s): demonstrated to result in appropriate increased incidence of micronucleated PCEs in mice
- Route of administration: IP
- Doses / concentrations: 12.5 mg/kg. Purchased from Eastman Kodak (Rochester, NY, USA).
Examinations
- Tissues and cell types examined:
- bone marrow
- Details of tissue and slide preparation:
- Duplicate slides were prepared fixed in absolute methanol and stained with acridine orange
- Evaluation criteria:
- Bone marrow smears were evaluated using fluorescence microscopy for determination of the percentage of polychromatic erythrocytes and micronucleated erythrocytes. Two hundred erythrocytes were determined per slide. The maximum administered dose determination experiments were conducted to more accurately estimate the maximum dose to be tested in the primary MN test. The number of MN-PCEs were evaluated among 2000 PCEs, and the number of PCEs were determined among 200 erythrocytes. The initial test utilized bone marrow tissue. In some cases peripheral blood smears (obtained 2 days after the last treatment in the dose determination experiment) were scored to verify a positive result in the initial bone marrow MN test. The frequency of MN-PCE among 2000 PCE and the percentage of PCE among 2000 erythrocytes were determined. If peripheral blood smears were unavailable or did not exhibit a significant increase in MN-PCE, a second in vivo BM test was conducted.
- Statistics:
- The data were analyzed using a specially designed software package, the MN Assay Data Management and Statistical Software Package (version 1.4, ILS, 1990). The level of significance was set at an alpha level of 0.05. The number of MN-PCE was pooled within the each dose group and analysed using a trend Test (1-tailed), which incorporated a variance inflation factor to account for excess animal variablity. If the increase in the dose response curve is nonmonotonic, the software program allows for the data to be analysed for a significant positive trend after data at the highest dose only has been excluded. In this case, the alpha level is adjusted to 0.01 to protect against false positives. The % PCE data was analysed by an analysis of variance (ANOVA) test based on pooled data. Pairwise comparisons between each groups and the concurrent solvent control group was by an unadjusted 1-tailed Pearson chi-squared test which incorporated the calculated variance inflation factor for the study.
Results and discussion
Test results
- Key result
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- Initial results were negative at all doses through 1750 mg/kg. No mortality was observed at any dose.
Applicant's summary and conclusion
- Conclusions:
- The test was negative (not genotoxic). Formation of micronuclei in newly-formed bone marrow erythrocytes was not elevated in male mice after 3 IP administrations of DMTP up to the high dose of 1750 mg/kg bw (actual dose). This is the highest dose technically possible for suspension in the corn oil vehicle, and can be considered the limit dose, just shy of 2000 mg/kg bw. Data can be read-across from DMTP to dimethyl isophthalate (DMIP), based on common functional groups. The substances are isomers. The similarities in structure are likely to apply to metabolites as well, with DMIP breaking down to isophthalic acid, just as DMTP is known to break down to terephthalic acid; these are isomers. Similarity in structures and break-down products for the two substances is the basis for the reading-across of data for this endpoint. This is adequate to fulfill the information requirements of Annex IX, to be the basis for classification and labelling decisions, and for risk assessment.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.